Relative Mitochondrial Priming of Myeloblasts and Normal HSCs Determines Chemotherapeutic Success in AML von Vo, Thanh-Trang, Ryan, Jeremy, Carrasco, Ruben, Neuberg, Donna, Rossi, Derrick J., Stone, Richard M., DeAngelo, Daniel J., Frattini, Mark G., Letai, Anthony

Volltext

Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy von Chonghaile, Triona Ni, Sarosiek, Kristopher A., Vo, Thanh-Trang, Ryan, Jeremy A., Tammareddi, Anupama, Del Gaizo Moore, Victoria, Deng, Jing, Anderson, Kenneth C., Richardson, Paul, Tai, Yu-Tzu, Mitsiades, Constantine S., Matulonis, Ursula A., Drapkin, Ronny, Stone, Richard, DeAngelo, Daniel J., McConkey, David J., Sallan, Stephen E., Silverman, Lewis, Hirsch, Michelle S., Carrasco, Daniel Ruben, Letai, Anthony

Volltext

Targeting mTOR for the treatment of B cell malignancies von Lee, Jong‐Hoon Scott, Vo, Thanh‐Trang, Fruman, David A.

Volltext

Nuclear FAK Promotes Cell Proliferation and Survival through FERM-Enhanced p53 Degradation von Lim, Ssang-Taek, Chen, Xiao Lei, Lim, Yangmi, Hanson, Dan A., Vo, Thanh-Trang, Howerton, Kyle, Larocque, Nicholas, Fisher, Susan J., Schlaepfer, David D., Ilic, Dusko

Volltext

Targeting eIF4F translation complex sensitizes B-ALL cells to tyrosine kinase inhibition von Vo, Thanh-Trang, Herzog, Lee-or, Buono, Roberta, Lee, Jong-Hoon Scott, Mallya, Sharmila, Duong, Madeleine R., Thao, Joshua, Gotesman, Moran, Fruman, David A.

Volltext

INPP4B Is a Tumor Suppressor in the Context of PTEN Deficiency von Vo, Thanh-Trang T, Fruman, David A

Volltext

mTOR inhibition enhances efficacy of dasatinib in ABL -rearranged Ph-like B-ALL von Gotesman, Moran, Vo, Thanh-Trang T, Herzog, Lee-Or, Tea, Tiffeny, Mallya, Sharmila, Tasian, Sarah K, Konopleva, Marina, Fruman, David A

Volltext

mTORC1 Inhibition Induces Resistance to Methotrexate and 6-Mercaptopurine in Ph + and Ph-like B-ALL von Vo, Thanh-Trang T, Lee, J Scott, Nguyen, Duc, Lui, Brandon, Pandori, William, Khaw, Andrew, Mallya, Sharmila, Lu, Mengrou, Müschen, Markus, Konopleva, Marina, Fruman, David A

Volltext

mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill B-cell acute lymphoblastic leukemia cells von Beagle, Brandon R, Nguyen, Duc M, Mallya, Sharmila, Tang, Sarah S, Lu, Mengrou, Zeng, Zhihong, Konopleva, Marina, Vo, Thanh-Trang, Fruman, David A

Volltext

MCL-1-independent mechanisms of synergy between dual PI3K/mTOR and BCL-2 inhibition in diffuse large B cell lymphoma von Lee, J Scott, Tang, Sarah S, Ortiz, Veronica, Vo, Thanh-Trang, Fruman, David A

Volltext

Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemia von Bhola, Patrick D, Mar, Brenton G, Lindsley, R Coleman, Ryan, Jeremy A, Hogdal, Leah J, Vo, Thanh Trang, DeAngelo, Daniel J, Galinsky, Ilene, Ebert, Benjamin L, Letai, Anthony

Volltext

Pretibial myxedema in Grave's disease: A case report and treatment review of the literature von Nguyen, Van Bang, Nguyen, Van Vy Hau, Van Le, Chi, Linh, Pham Nguyen Tuyen, Thi, Xuan Nguyen, Vo, Thanh Trang

Volltext

Synthesis of the C1-phosphonate analog of UDP-GlcNAc von Chang, Robert, Vo, Thanh-Trang, Finney, Nathaniel S.

Volltext

Hydrogen-bonding as a tool for building one-dimensional structures based on dimetal building blocks von Bera, Jitendra K., Vo, Thanh-Trang, Walton, Richard A., Dunbar, Kim R.

Volltext

The Role of Lung Ultrasonography in Etiologic Diagnosis of Acute Dyspnea in a Resource Limited Setting von Phung, Nguyen The Nguyen, Vo, Trang Thi Thanh, Hon, Kam Lun Ellis

Volltext

Abstract 5477: mTOR inhibitors protect from apoptosis in B-ALL cells treated with chemotherapeutic drugs von Vo, Thanh-Trang, Fruman, David A.

Volltext

Development of Cirmtuzumab Antibody-Drug Conjugates (ADCs) Targeting Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) von Mian, Yousaf A., Widhopf II, George F., Vo, Thanh-Trang, Jessen, Katti, Rassenti, Laura Z., Kipps, Thomas J.

Volltext

Abstract 3851: Synergy between statins and BCL-2 inhibitors in blood cancers von Lee, Jong-Hoon S., Vo, Thanh-Trang T., Fruman, David A.

Volltext

Abstract IA17: Strategies to target the mTORC1/eIF4F axis in B-cell leukemia and lymphoma von Herzog, Lee-or, Lee, Bianca J., Vo, Thanh-Trang, Chiu, Honyin, Mallya, Sharmila, Fung, Amos, Singh, Mallika, Aggen, James, Tibrewal, Nidhi, Smith, Jacqueline A.M., Wildes, David, Ronai, Ze'ev, Ruggero, Davide, Fruman, David A.

Volltext

Vls-101 Is a Novel Therapeutic Antibody-Drug Conjugate (ADC) Targeting Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) in Richter's Syndrome (RS) von Vaisitti, Tiziana, Jessen, Katti, Vo, Thanh-Trang, Ko, Mira, Arruga, Francesca, Vitale, Nicoletta, Braggio, Esteban, Di Napoli, Arianna, Chadburn, Amy, Allan, John N., Furman, Richard R., Miller, Langdon L., Lanutti, Brian J, Deaglio, Silvia

Volltext